UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
Commission File Number |
001-36403 |
IKANG HEALTHCARE GROUP, INC.
(Exact name of registrant as specified in its charter)
B-6F, Shimao Tower
92A Jianguo Road
Chaoyang District, Beijing 100022
People’s Republic of China
Tel: +86 10 5320 6688
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Class A Common Shares, par value US$0.01 per share
American Depositary Shares, each representing 1/2 Class A Common Shares
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
Rule 12g-4(a)(1) |
x |
|
|
|
|
|
|
Rule 12g-4(a)(2) |
o |
|
|
|
|
|
|
Rule 12h-3(b)(1)(i) |
x |
|
|
|
|
|
|
Rule 12h-3(b)(1)(ii) |
o |
|
|
|
|
|
|
Rule 15d-6 |
o |
|
|
|
|
|
|
Rule 15d-22(b) |
o |
|
|
|
|
Approximate number of holders of record as of the certification or notice date: one
Pursuant to the requirements of the Securities Exchange Act of 1934, iKang Healthcare Group, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
Date: |
January 31, 2019 |
|
iKang Healthcare Group, Inc. |
| |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Lee Ligang Zhang |
|
|
|
|
|
Name: |
Lee Ligang Zhang |
|
|
|
|
|
Title: |
Chief Executive Officer |
|